Lyra Therapeutics, Inc. (LYRA)
NASDAQ·Healthcare·Biotechnology
$0.55
-58.33%
Mkt Cap $2.31M
Mkt Cap
$2.31M
P/E
—
Fwd P/E
—
P/S
1.96
Rev TTM
—
EPS TTM
-$1.86
NASDAQ·Healthcare·Biotechnology
$0.55
-58.33%
Mkt Cap $2.31M
Mkt Cap
$2.31M
P/E
—
Fwd P/E
—
P/S
1.96
Rev TTM
—
EPS TTM
-$1.86